Directory

>

Susan Low

Susan Low

Senior Vice President | eGenesis, Inc.

Cambridge, Massachusetts, United States

View contact details (it's free)

Susan Low

Summary

Susan Low is a seasoned pharmacologist and toxicologist with a robust background in biologics, small molecules, and nanotherapeutics, specializing in the development of oral extended release dosage forms. With extensive experience spanning early research to clinical evaluation in areas such as hemophilia, oncology, and neurological conditions, she has played pivotal roles in various organizations. Currently serving as the Senior Vice President at eGenesis, Inc., she leads xenotransplant development programs, overseeing complex regulatory and clinical activities. Susan's academic foundation includes a PhD from The University of Edinburgh, which complements her practical experience in the pharmaceutical industry. Her expertise extends to project management and toxicology, particularly in oncology and immunology. Beyond her technical skills, she is recognized for her leadership in advancing innovative therapeutic solutions that enhance patient adherence to medication. Susan's career reflects a commitment to scientific excellence and a passion for improving healthcare outcomes.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Susan Low

Work Experience

company logo

Senior Vice President at

eGenesis, Inc.

June 2022 - Present

company logo

Vice President at

Verseau Therapeutics

July 2019 - Present

company logo

Vice President at

eGenesis, Inc.

October 2021 - June 2022

💼

Vice President Pharmacology and Toxicology at

LYNDRA TOV

January 2018 - June 2019

💼

Head of Pharmacology, Toxicology and Biology at

LYNDRA TOV

July 2016 - January 2018

company logo

Senior Director at

BIND Therapeutics

March 2013 - April 2016

company logo

Head of Biology at

Bind Biosciences Inc.

January 2009 - March 2013

💼

Associate Director, Cell Biology and in vivo Pharmacology at

Syntonix Pharmaceuticals

October 1999 - December 2008

company logo

Postdoctoral Scientist at

Massachusetts Institute of Technology

January 1996 - January 1999

company logo

Postdoctoral Scientist at

Harvard University

January 1994 - January 1996

Logos provided by Logo.dev

Susan Low

Education

The University of Edinburgh, Phd

January 1990 - January 1994

Frequently Asked Questions about Susan Low

What is Susan Low email address?

Susan Low's primary email address is *****@verseautx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Susan Low work for?

Susan Low is a Senior Vice President at eGenesis, Inc., a company specializing in Commercial physical research.

Where Susan Low graduated from?

Susan Low holds a degree in Biology from The University of Edinburgh.

How can I directly contact Susan Low?

To contact Susan Low directly, you can use the email address *****@verseautx.com. Complete contact information is available upon registration with Muraena.

Who is Susan Low?

Susan Low is a seasoned pharmacologist and toxicologist with a robust background in biologics, small molecules, and nanotherapeutics, specializing in the development of oral extended release dosage forms. With extensive experience spanning early research to clinical evaluation in areas such as hemophilia, oncology, and neurological conditions, she has played pivotal roles in various organizations. Currently serving as the Senior Vice President at eGenesis, Inc., she leads xenotransplant development programs, overseeing complex regulatory and clinical activities. Susan's academic foundation includes a PhD from The University of Edinburgh, which complements her practical experience in the pharmaceutical industry. Her expertise extends to project management and toxicology, particularly in oncology and immunology. Beyond her technical skills, she is recognized for her leadership in advancing innovative therapeutic solutions that enhance patient adherence to medication. Susan's career reflects a commitment to scientific excellence and a passion for improving healthcare outcomes.

Susan`s contact details

mail

*****@verseautx.com

Colleagues

avatar
Jose Torres-Serrano

Vice President, Quality

avatar
James Olesen

Vice President of Intellectual Property & Legal

avatar
Wenning Qin

SVP, Research

avatar
Jennifer Bergheiser

Chief Business Officer

avatar
Michael Curtis

President and CEO

avatar
Al Wiegman

Board Member

View Contact details (it's free)
Request Profile Removal